Molecule to Market is proudly sponsored by Bora Pharmaceuticals - The premium CDMO partner

Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 267

    The Indiana boy driving CGT development

    Sean Werner

    / BioLife Solutions

    Sean Werner, Chief Technology Officer at BioLife Solutions talks about his experience from becoming a scientist to a business leader.

  • Episode 266

    DCAT Live – Morgan Stanley CDMO CEO Dinner

    Alessandro Maselli, Franco Negron

    / Catalent, Simtra BioPharma Solutions

    A live fireside chat with Alessandro Maselli, President and CEO at Catalent and Franco Negron, CEO at Simtra BioPharma Solutions.

  • Episode 265

    DCAT Live Panel – Stick or Twist with Capacity in Times of Uncertainty

    Sarah Stevens, Dirk Lange, Jake Behrman, Hanns-Christian Mahler, J.D. Mowery,

    / Chrysalis, Pyramid Pharma, 3i, ten23, AST/Engage,

    A live panel with our host from DCAT, New York with Dirk Lange, Hanns-Christian Mahler, Jake Behrman, J.D. Mowery and Sarah Stevens.

  • Episode 264

    From consulting stay at home dad to global CRO CEO

    Greg Plunkett

    / Accelagen

    Greg Plunkett, Founder and CEO of Accelagen talks about his pharma experience from concept to commercialisation and clinical trial ecosystem.

  • Episode 263

    From big pharma manufacturing lead to CDMO CEO

    Joerg Ahlgrimm

    / SK pharmteco

    Joerg Ahlgrimm, CEO of SK pharmteco talks about his 25+ years experience in building and managing CDMO relationships.

  • Episode 262

    M2M Pulse: 7 Trends CDMO You Can’t Ignore

    Raman Sehgal

    / Molecule To Market

    Our host Raman Sehgal talks about 7 trends that CDMOs should not ignore in 2026. The final instalment of the Pulse Survey Series.

  • Episode 261

    25+ years & 200+ deals – meet the prolific pharma dealmaker

    Banks Bourne

    / Bourne Partners

    Banks Bourne, Founder & Chief Executive Officer at Bourne Partners talks about his experience investing in the right place at the right time.

  • Episode 260

    The 30-year, overnight success

    Julian Casciano

    / eMAX Health

    Julian Casciano, President & CEO at eMAX Health talks about how his personal experience shaped his path into healthcare.

  • Episode 259

    The CDMO CEO Operator Playbook for 2026

    Raman Sehgal

    / Molecule To Market

    Our host Raman Sehgal talks about the internal challenges and biggest opportunities CDMO CEOs face in 2026.

  • Episode 258

    The AI CEO changing pharma from the inside

    Pep Gubau

    / Aizon

    Pep Gubau, CEOm, CTO & Co-Founder at Aizon talks about the role that AI plays in the pharma manufacturing industry.

  • Load more